ARCHIVES

NCI Exceeded Mandate In Study Of Legislators, Rep. Porter Says

This article is from The Cancer Letter archive.

Vol. 21 No. 32 | August 11, 1995

Download PDF Visit The Full Archive

Related Articles

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

March 16, 2007

Van Nevel New NCI information Chief: Karel Leaves For Johnson Foundation

August 30, 1974

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

NCA Okays New Centers Category For Environmental Carcinogenesis

July 4, 1975

ASCO Sees Efforts Pay Off In Health Care Reform: Clinical Trials

October 1, 1993